Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors

Dr. William Brody, President of the Salk Institute for Biological Studies,
Appointed to GenVault's Board of Directors

CARLSBAD, Calif., Nov. 4 /PRNewswire/ -- GenVault Corporation (Carlsbad, CA)
today announces that William Brody, M.D., Ph.D., has joined its Board of
Directors. Dr. Brody, the Irwin Jacobs Presidential Chair of the Salk
Institute, is an acclaimed physician-scientist and university leader. Prior
to joining the Salk Institute, Dr. Brody served as president of The Johns
Hopkins University. He is a member of the National Academy of Engineering and
the Institute of Medicine, and is renowned for his academic achievements and
his contributions to the field of biomedical engineering. Further, Dr. Brody
co-founded three medical device companies and holds two U.S. patents in the
field of medical imaging.

"We are all excited to welcome Dr. Brody to our Board of Directors and are
extremely privileged to work with such a high caliber and accomplished
individual," said Dr. David Wellis, President and CEO of GenVault Corporation.
"The impressive depth of academic, engineering and medical experience and
national and international credibility that Dr. Brody brings with him will be
key in guiding our strategic focus as GenVault continues its expansion from
biobanking into the genomic transport and analysis markets," continued Dr.
Wellis.

Dr. Brody commented, "In this era of explosive growth for genomic analysis and
genetic testing, the number of DNA and RNA samples stored, transported and
analyzed is increasing exponentially. GenVault's products and technologies
help researchers keep pace with this increase and also reduce the cost,
complexity and waste associated with existing sample management methods. I
look forward to working with GenVault as we develop and bring to market
further innovative and sustainable sample management solutions for the life
science and clinical marketplaces," said Dr. Brody.

Dr. Brody received his B.S. and M.S. degrees in electrical engineering from
the Massachusetts Institute of Technology. He received his Ph.D. (also in
electrical engineering) and his M.D. degrees from Stanford University.

Dr. Brody currently serves on a number of national boards, including IBM,
Stanford University, and Novartis. He is a member of the Scientific
Management Review Board of the National Institutes of Health. Dr. Brody has
also been a national figure in efforts to encourage innovation and strengthen
the U.S. economy through investments in research and education.

About GenVault
GenVault is the global leader in providing risk free biosample workflow,
transport, and storage solutions for genomic medicine, discovery and
identification. Today, GenVault is empowering pharmaceutical companies,
medical centers, academic institutions and law enforcement agencies to more
fully leverage the rapidly growing genomics industry. As a scalable, reliable
and environmentally friendly alternative to traditional freezers and DNA
purification systems, the company's dry-state platform enables the extraction,
preservation, recovery, and distribution of biosamples at ambient temperature.
Future systems will also accommodate proteins and RNA to provide a
comprehensive solution. From GenPlates to the Dynamic Archive, GenVault is
continuously developing and refining best practices for biosample management
and preservation. For more information visit GenVault at www.genvault.com.

Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
David Wellis
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91851

CONTACT:
David Wellis
President & CEO
(760) 268-5256
dwellis@genvault.com

SOURCE GenVault Corporation

David Wellis, President & CEO of GenVault Corporation, +1-760-268-5256,
dwellis@genvault.com